COVID-19
Group by:
Date (Most Recent First)
Industry
Subject
Region
Go
Today is March 19, 2024. All times in Eastern Daylight Time.
Edgewise Therapeutics to Showcase Novel Cardiac Program at Virtual Investor Event on Tuesday, January 3, 2023
12/21/2022 - 09:00 AM
BUSINESS WIRE
AshBritt Teams up With Operation BBQ Relief and Carhartt to Bring Christmas Meals to Families in Hazard, Kentucky
12/21/2022 - 09:00 AM
BUSINESS WIRE
Empire State Realty Trust Provides Business Update
12/21/2022 - 08:58 AM
BUSINESS WIRE
The Toro Company Reports Record Results for the Fourth-Quarter and Full-Year Fiscal 2022
12/21/2022 - 08:30 AM
BUSINESS WIRE
FG Financial Group Announces Formation Of Reinsurance Sidecar To Support Growth of Reinsurance Business
12/21/2022 - 08:30 AM
BUSINESS WIRE
Cintas Corporation Announces Fiscal 2023 Second Quarter Results
12/21/2022 - 08:30 AM
BUSINESS WIRE
Capstone Green Energy Secures Order for a 600kW Energy System From a Leading Slovenian Dairy Producer, Pomurske Mlekarne
12/21/2022 - 08:20 AM
BUSINESS WIRE
HarborOne Bancorp, Inc. Declares Fourth Quarter Cash Dividend
12/21/2022 - 08:00 AM
BUSINESS WIRE
Evolv Technology Announces $75 Million in Non-Dilutive Debt Financing with Silicon Valley Bank
12/21/2022 - 08:00 AM
BUSINESS WIRE
TVD Holdings PCL Improves Sales Effectiveness and Agent Satisfaction with NICE Interaction Analytics
12/21/2022 - 08:00 AM
BUSINESS WIRE
Alnylam Submits CTA Application for ALN-KHK, an Investigational RNAi Therapeutic for the Treatment of Type 2 Diabetes
12/21/2022 - 08:00 AM
BUSINESS WIRE
Enveric Biosciences to Present at the 6th Annual Neuroscience Innovation Forum and Biotech Showcase during "J.P. Morgan Health Care Week 2023"
12/21/2022 - 07:30 AM
BUSINESS WIRE
Arrowhead Pharmaceuticals to Present Topline Data from the Phase 2 SEQUOIA Study Evaluating Fazirsiran and Describe Design for Planned Phase 3 Study
12/21/2022 - 07:30 AM
BUSINESS WIRE
Aldeyra Therapeutics Submits New Drug Application to the U.S. Food and Drug Administration for ADX‑2191 for the Treatment of Primary Vitreoretinal Lymphoma
12/21/2022 - 07:00 AM
BUSINESS WIRE
Rite Aid Corporation Reports Fiscal 2023 Third Quarter Results
12/21/2022 - 07:00 AM
BUSINESS WIRE
1
...
4
5
6
7
8
9
10
11
12
13
14
...
6092
« Previous
Next »
Site Navigation
Home
Home
Submit a Press Release
Services
News
All News
News with Multimedia
News by Industry
News by Subject
News by Language
Tradeshows & Events
Education
Overview
Blog
Distribution & Media
Media & Journalist Tools
Sample Press Release
Find Your News Online
Disclosure Resources
About Us
Overview
Become a Member
Contact Us
Careers
Business Wire Newsroom
Business Wire Events
Search
Advanced News Search
Advanced News Search
Log In
Sign Up